Performance of small diameter synthetic vascular prostheses with confluent autologous endothelial cell linings
- PMID: 9019487
- DOI: 10.1002/(SICI)1097-4636(199602)30:2<221::AID-JBM12>3.0.CO;2-P
Performance of small diameter synthetic vascular prostheses with confluent autologous endothelial cell linings
Abstract
Autologous grafts are superior to their synthetic counter-parts for grafting arteries smaller than 6-mm diameter both in terms of acute thrombogenicity and chronic intimal hyperplasia. Endothelial cell (EC) coating of the blood contacting surface may reduce thrombogenicity of synthetic small diameter vascular prostheses. In this study, the survival of EC monolayers on synthetic 4-mm diameter arterial prostheses over short-term implantations (< or = 6 weeks) was examined. Graft types examined were expanded polytetra-fluoroethylene (ePTFE) and microporous polyurethane (PU). Lumenal coverage with ECs was achieved by culturing ovine ECs on prostheses treated by either physical adsorption or covalent binding of ovine fibronectin (Fn). An ovine carotid interposition model was used to examine the performance of EC coated ePTFE and microporous PU over implantation periods of 1, 3, and 6 weeks. Outcomes assessed at the end of each experiment were graft patency, area covered by ECs, and thrombus free surface area (TFSA). Fn concentration, cell density at the time of coating and prostacyclin production in vitro were similar for both graft types. Occlusion occurred more frequently in unseeded grafts compared with EC coated grafts over 3 and 6 week implantation periods; however, the difference was not significant (p = 0.099). In prostheses precoated with ECs, approximately 40-60% of the surface area remained covered with endothelial-like cells following the first postoperative week. Recovery of EC layers occurred rapidly thereafter with 80-90% coverage at 3 weeks. TFSA remained low in comparison to EC cover in these prostheses until between 3 and 6 weeks postoperatively, suggesting a lag phase in recovery of EC function of seeded cells. In contrast, EC cover of unseeded prostheses only achieved 10-30% at 3 weeks, primarily by pannus EC ingrowth from the adjacent artery. TFSA of unseeded grafts increased in direct proportion to EC cover over time suggesting that there was no lag phase in function of these ingrowing cells.
Similar articles
-
In vivo patency of endothelial cell-lined expanded polytetrafluoroethylene prostheses in an ovine model.Artif Organs. 1992 Aug;16(4):346-53. doi: 10.1111/j.1525-1594.1992.tb00530.x. Artif Organs. 1992. PMID: 10078273
-
Improved adherence of genetically modified endothelial cells to small-diameter expanded polytetrafluoroethylene grafts in a canine model.J Vasc Surg. 1998 May;27(5):902-8; discussion 908-9. doi: 10.1016/s0741-5214(98)70271-x. J Vasc Surg. 1998. PMID: 9620143
-
Effects of retroviral-mediated tissue plasminogen activator gene transfer and expression on adherence and proliferation of canine endothelial cells seeded onto expanded polytetrafluoroethylene.J Vasc Surg. 1995 Dec;22(6):795-803. doi: 10.1016/s0741-5214(95)70071-4. J Vasc Surg. 1995. PMID: 8523615
-
Clinical performance of vascular grafts lined with endothelial cells.Endothelium. 1999;6(4):267-75. doi: 10.3109/10623329909078494. Endothelium. 1999. PMID: 10475090 Review.
-
Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides?Anat Rec. 2001 Aug 1;263(4):379-87. doi: 10.1002/ar.1118. Anat Rec. 2001. PMID: 11500815 Review.
Cited by
-
Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells.Gene Ther. 2016 Mar;23(3):237-46. doi: 10.1038/gt.2015.104. Epub 2015 Dec 24. Gene Ther. 2016. PMID: 26588709
-
Tissue responses to endovascular stent grafts for saccular abdominal aortic aneurysms in a canine model.J Korean Med Sci. 2012 Oct;27(10):1170-6. doi: 10.3346/jkms.2012.27.10.1170. Epub 2012 Oct 2. J Korean Med Sci. 2012. PMID: 23091313 Free PMC article.
-
Effects of thermal annealing of segmented-polyurethane on surface properties, structure and antithrombogenicity.J Mater Sci Mater Med. 2002 Mar;13(3):259-64. doi: 10.1023/a:1014054716444. J Mater Sci Mater Med. 2002. PMID: 15348622
-
Streptavidin binding and endothelial cell adhesion to biotinylated fibronectin.Langmuir. 2007 Dec 4;23(25):12583-8. doi: 10.1021/la702322n. Epub 2007 Nov 7. Langmuir. 2007. PMID: 17985940 Free PMC article.
-
In Vivo Application of Tissue-Engineered Veins Using Autologous Peripheral Whole Blood: A Proof of Concept Study.EBioMedicine. 2014 Sep 22;1(1):72-9. doi: 10.1016/j.ebiom.2014.09.001. eCollection 2014 Nov. EBioMedicine. 2014. PMID: 26137509 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous